Literature DB >> 2938069

Pharmacokinetics of intravenously administered ciprofloxacin in intensive care patients with acute renal failure.

M S Dirksen, T B Vree.   

Abstract

The pharmacokinetics of ciprofloxacin after a single intravenous administration of 100 mg were studied in intensive care patients with an acute renal impairment. There was no correlation found between the creatinine clearance and the renal clearance of ciprofloxacin. This applies to the entire group of patients. The decrease in renal clearance of ciprofloxacin was, however, more pronounced than the change in the elimination half-life, suggesting an important extra-renal elimination of the drug.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938069     DOI: 10.1007/bf01975477

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  9 in total

1.  Pharmacokinetics of intravenously administered ciprofloxacin.

Authors:  R Wise; R M Lockley; M Webberly; J Dent
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

2.  Dose- and sex-independent disposition of ciprofloxacin.

Authors:  D Höffler; A Dalhoff; W Gau; D Beermann; A Michl
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

3.  Multiple-dose ciprofloxacin kinetics in normal subjects.

Authors:  G E Aronoff; C H Kenner; R S Sloan; S T Pottratz
Journal:  Clin Pharmacol Ther       Date:  1984-09       Impact factor: 6.875

4.  Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers.

Authors:  W Wingender; K H Graefe; W Gau; D Förster; D Beermann; P Schacht
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

5.  Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans.

Authors:  J M Brogard; F Jehl; H Monteil; M Adloff; J F Blickle; P Levy
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

6.  The pharmacokinetics of ciprofloxacin in patients with impaired renal function.

Authors:  J Boelaert; Y Valcke; M Schurgers; R Daneels; M Rosseneu; M T Rosseel; M G Bogaert
Journal:  J Antimicrob Chemother       Date:  1985-07       Impact factor: 5.790

7.  Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine.

Authors:  B Joos; B Ledergerber; M Flepp; J D Bettex; R Lüthy; W Siegenthaler
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

8.  Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.

Authors:  M A Gonzalez; F Uribe; S D Moisen; A P Fuster; A Selen; P G Welling; B Painter
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

9.  Pharmacokinetics: metabolism and renal excretion of quinolones in man.

Authors:  T B Vree; W J Wijnands; P J Guelen; A M Baars; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1986-02-21
  9 in total
  3 in total

1.  Influence of renal failure on ciprofloxacin pharmacokinetics in rats.

Authors:  B Nouaille-Degorce; C Veau; S Dautrey; M Tod; D Laouari; C Carbon; R Farinotti
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

Review 2.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

3.  Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.

Authors:  W J Wijnands; T B Vree; A M Baars; C L van Herwaarden
Journal:  Drugs       Date:  1987       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.